Deborah O'Neil

806 posts

Deborah O'Neil banner
Deborah O'Neil

Deborah O'Neil

@debsoneil

Biotechnology entrepreneur. Founder and CEO of NovaBiotics. Immunologist designing and developing much needed novel antimicrobial strategies for over 20 years.

Aberdeen, UK Katılım Temmuz 2014
212 Takip Edilen521 Takipçiler
Deborah O'Neil
Deborah O'Neil@debsoneil·
Not only did the ‘driver’ ensure a 2 min silence either side of 1100, but I’m sure he dipped a wing at 1100 (not checking in case that was just a headwind coincidence…) Well done #Loganair
English
0
0
2
171
Deborah O'Neil retweetledi
Royal Society of Edinburgh
Royal Society of Edinburgh@RoyalSocEd·
That's one week down of Curious 2023 - but there's still loads to come... We've had a fantastic first week delving under the surface - from forensic science to primate research and everything in between! Don't miss out on our exciting programme & visit rse-curious.com
Royal Society of Edinburgh tweet mediaRoyal Society of Edinburgh tweet mediaRoyal Society of Edinburgh tweet mediaRoyal Society of Edinburgh tweet media
English
0
2
6
919
Deborah O'Neil retweetledi
NovaBiotics Ltd
NovaBiotics Ltd@NovaBiotics·
Community Acquired Pneumonia (CAP) is an unmet global health & socioeconomic issue. Prevalence is increasing and a challenging winter CAP season driven by COVID, influenza & bacterial infections looms. Read more about NM002, our immunomodulator-antimicrobial candidate therapy 👇
NovaBiotics Ltd tweet media
English
0
3
8
0
Deborah O'Neil retweetledi
Larry the Cat
Larry the Cat@Number10cat·
“I can no longer, in good conscience, live with this Prime Minister. Either he goes, or I do”
Larry the Cat tweet media
English
1.9K
33.8K
203.6K
0
Deborah O'Neil retweetledi
NovaBiotics Ltd
NovaBiotics Ltd@NovaBiotics·
Community Acquired Pneumonia (CAP) remains a significant cause of morbidity & mortality. At #eccmid @dougfp78 will present new data on NM002, our immunomodulatory-antimicrobial candidate in phase 3 clinical development for CAP. Posters L0185, April 24th & L0476, April 25th
NovaBiotics Ltd tweet media
English
0
4
6
0
Deborah O'Neil retweetledi
BEAM Alliance
BEAM Alliance@AllianceBEAM·
The #EU Pharma Legislation revision is on the horizon. What solutions do #SMEs need from our policymakers to unlock the innovation potential to tackle #AMR? Check out this video and don’t hesitate to spread the voice of SMEs too: like, share, and comment! bit.ly/3K057dv
English
0
9
19
0
Deborah O'Neil
Deborah O'Neil@debsoneil·
Our latest publication, drilling further down into the mechanism of NM001 against Pseudomonas aeruginosa, still a major, poorly served driver of pathology in #cysticfibrosis. NM001 has potential in #CF, but also in other respiratory disease & against other bacterial pathogens👇👇
NovaBiotics Ltd@NovaBiotics

Very pleased to share further mechanistic insights highlighting the potential of our NM001 therapy candidate for #cysticfibrosis. Our latest publication is now out in a special Pseudomonas aeruginosa focused edition of @FrontiersIn frontiersin.org/article/10.338…

English
0
2
5
0
Deborah O'Neil
Deborah O'Neil@debsoneil·
Congratulations to all of this years' unstoppable #EOYUK finalists 👏✨
English
0
0
2
0
Deborah O'Neil
Deborah O'Neil@debsoneil·
@EOY_UK @NovaBiotics An absolute pleasure to be back on the UK panel & looking forward very much to spending time with this years’ amazing finalists & my esteemed judging teammates.
English
0
0
1
0